| 4/10/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 12,836,489 | $1.54M | +11.2%hist | +5.59%hist |
| 4/10/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 3,172,769 | $380.7K | +11.2%hist | +5.59%hist |
| 4/10/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 534,855 | $64.2K | +11.2%hist | +5.59%hist |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | Jeffery KatherineChief People Officer | SELL | 7,096 | $8.0K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | Maricich YuriChief Medical Officer | SELL | 12,162 | $13.7K | +105.8%hist | +117.6%hist |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | GUIFFRE CHRISTOPHERD TCFO, COO, Treas., & Asst. Sec. | SELL | 19,540 | $22.1K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | Brenner Erin K.Chief Product Dev. Officer | SELL | 8,690 | $9.8K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | Strandberg JuliaChief Commercial Officer | SELL | 12,688 | $14.3K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | O'Brien RonanGC, CCO & Secretary | SELL | 12,162 | $13.7K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | Snow EllenChief Accounting Officer | SELL | 8,027 | $9.1K | — | — |
| 1/20/2023 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | McCann CoreyPresident and CEO | SELL | 34,731 | $39.2K | — | — |
| 11/15/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 61,222 | $154.3K | +11.2%hist | +5.59%hist |
| 11/15/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 2,551 | $6.4K | +11.2%hist | +5.59%hist |
| 11/14/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 485 | $1.4K | +11.2%hist | +5.59%hist |
| 11/14/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 11,643 | $32.5K | +11.2%hist | +5.59%hist |
| 11/11/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 1,175 | $3.7K | +11.2%hist | +5.59%hist |
| 11/11/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 28,205 | $90.0K | +11.2%hist | +5.59%hist |
| 11/2/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 423 | $1.2K | +11.2%hist | +5.59%hist |
| 11/2/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 10,155 | $27.6K | +11.2%hist | +5.59%hist |
| 11/1/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 59 | $165.20 | +11.2%hist | +5.59%hist |
| 11/1/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 1,408 | $3.9K | +11.2%hist | +5.59%hist |
| 10/31/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 40,477 | $112.5K | +11.2%hist | +5.59%hist |
| 10/31/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 1,687 | $4.7K | +11.2%hist | +5.59%hist |
| 9/16/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 14 | $24.50 | +11.2%hist | +5.59%hist |
| 9/16/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 337 | $589.75 | +11.2%hist | +5.59%hist |
| 9/15/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 10,910 | $19.7K | +11.2%hist | +5.59%hist |
| 9/15/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 261,840 | $473.9K | +11.2%hist | +5.59%hist |
| 9/14/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 11,403 | $22.1K | +11.2%hist | +5.59%hist |
| 9/14/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 273,664 | $530.9K | +11.2%hist | +5.59%hist |
| 9/8/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 12,173 | $22.0K | +11.2%hist | +5.59%hist |
| 9/8/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 292,149 | $528.8K | +11.2%hist | +5.59%hist |
| 9/7/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 148,337 | $284.8K | +11.2%hist | +5.59%hist |
| 9/7/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 6,181 | $11.9K | +11.2%hist | +5.59%hist |
| 9/6/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 298,714 | $705.0K | +11.2%hist | +5.59%hist |
| 9/6/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 12,446 | $29.4K | +11.2%hist | +5.59%hist |
| 8/18/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 8,910 | $13.8K | +11.2%hist | +5.59%hist |
| 8/18/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 213,851 | $331.5K | +11.2%hist | +5.59%hist |
| 8/17/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 9,674 | $16.5K | +11.2%hist | +5.59%hist |
| 8/17/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 403 | $689.13 | +11.2%hist | +5.59%hist |
| 8/16/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 160,476 | $285.6K | +11.2%hist | +5.59%hist |
| 8/16/2022 | | PEARPear Therapeutics, Inc Pear Therapeutics, Inc | 5AM Co-Investors IV, L.P. · 5AM Opportunities I (GP), LLC · 5AM Opportunities I, L.P. · 5AM Partners IV, LLC · 5AM Ventures IV, L.P. · DIEKMAN JOHN D · ROCKLAGE SCOTT M · Schwab Andrew J.10% owner | SELL | 6,686 | $11.9K | +11.2%hist | +5.59%hist |